BridgeBio Pharma to Participate in September Investor Events

Rhea-AI Summary

BridgeBio Pharma (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases, has announced its participation in three major investor conferences in September 2024:

1. Morgan Stanley 22nd Annual Global Health Care Conference in New York, NY on September 4th at 10:00 am ET (Fireside Conversation)
2. Wells Fargo 19th Annual Healthcare Conference 2024 in Boston, MA on September 5th
3. Cantor Global Healthcare Conference in New York, NY on September 17th at 10:20 am ET (Presentation)

Investors can access live webcasts of BridgeBio's presentations on the company's website. Replay of the webcasts will be available for 90 days following each event.

News Market Reaction – BBIO

-0.32%

-0.32% Session move

In the trading session that priced this news, BBIO declined 0.32%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences:

• Morgan Stanley 22^nd Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4^th at 10:00 am ET
• Wells Fargo 19^th Annual Healthcare Conference 2024, Boston, MA, September 5^th
• Cantor Global Healthcare Conference, New York, NY: Presentation on September 17^th at 10:20 am ET
  

To access the live webcast of BridgeBio’s presentations, please visit the “Events” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.

About BridgeBio Pharma, Inc.

BridgeBio Pharma (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015, and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter and Facebook.

BridgeBio Contact:
Vikram Bali
contact@bridgebio.com
(650)-789-8220

FAQ

What investor events will BridgeBio Pharma (BBIO) participate in during September 2024?

BridgeBio Pharma will participate in three investor events in September 2024: Morgan Stanley Global Health Care Conference on September 4th, Wells Fargo Healthcare Conference on September 5th, and Cantor Global Healthcare Conference on September 17th.

When and where is BridgeBio Pharma's (BBIO) presentation at the Cantor Global Healthcare Conference?

BridgeBio Pharma will present at the Cantor Global Healthcare Conference in New York, NY on September 17th, 2024 at 10:20 am ET.

How can investors access BridgeBio Pharma's (BBIO) presentations at the September 2024 conferences?

Investors can access live webcasts of BridgeBio Pharma's presentations on the 'Events' page within the Investors section of the company's website at https://investor.bridgebio.com.

How long will replays of BridgeBio Pharma's (BBIO) September 2024 conference presentations be available?

Replays of BridgeBio Pharma's conference presentations will be available on the company's website for 90 days following each event.